Increased DAG levels inhibit PKC, leading to defective activation of IRS-1/PI3K/AKT insulin signaling, downregulation of GLUT4 and forthcoming insulin resistance [170,172]. This evidence concerns the gene SLC2A4 and Insulin resistance.